Wealthspire Advisors (Maryland)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-34
Closed 2770
2017
Q4
$0 Hold
34
﹤0.01% 2747
2017
Q3
$0 Hold
34
﹤0.01% 2669
2017
Q2
$0 Buy
+34
New ﹤0.01% 2398